Mar 4, 2024 | Benefits preservation, Fair market reimbursement, MedBen University, Precision medicine
Invitations to two upcoming MedBen University (MBU) events have been emailed… the Municipality & Public Employer Roundtable on Wednesday, April 3, or the Private Employer Roundtable on Thursday, April 11. If you haven’t received an invite to your event...
Feb 20, 2024 | Alternative Reimbursement Strategies, Announcements, Benchmarks, Benefits preservation, Fair market reimbursement, MedBen University, Pharmacogenomics, Precision medicine, Roundtables, Specialty Drugs, Trend
MedBen University (MBU) is in session, so mark your calendar! As we mentioned in the last e-briefs, MBU launched its 23rd season last month with the Benefits Advisory Conference for brokers… and this Spring, MBU will be conducting two employer roundtables:...
Feb 6, 2024 | Claims, Claims data, Cost Savings, Drug costs, Gene therapy, Genetic testing, MedBen News, MedBen Rx, MedBen University, Pharmacogenics, Pharmacy Benefits Manager (PBM), Self-funding, Specialty Drugs, Stop-Loss
MedBen recently had the honor to welcome some of the most respected names in the benefits management industry. At the invitation-only 2024 Benefits Advisory Conference on January 26, attending brokers learned about health plan innovations that will help self-funded...
Apr 4, 2023 | Caroline Fraker, Carve-outs, Compliance, Cost Savings, Dialysis, MedBen University, Regulatory, Savings, Supreme Court
At this year’s MedBen University roundtables, Senior Vice President & CPO Caroline Fraker provided an eye-opening example of why the June 2022 United States Supreme Court decision in the matter of Marietta Memorial Hospital Employee Health Benefit Plan v....
Mar 31, 2023 | Claims, Claims Management, Direct-to-Employer Contracting, Forensic claims review, MedBen University, Medical necessity, Roundtables
Contracting directly with a health system offers employers pricing control, member access to high-quality local care, and the flexibility to create multiple benefit options. At this year’s MedBen University roundtables, Regional Sales Director Brooke Hupp...
Mar 21, 2023 | Brand Name Drugs, Diabetes, Drug costs, Generic Drugs, Insulin, Kurt Harden, MedBen Rx, MedBen University, Pharmacy Benefits Manager (PBM), Prescription
Earlier this month, drug manufacturer Eli Lilly announced that it cutting the cost of two of its prescription brand insulins, Humalog and Humulin, by 70%, and capping out-of-pocket costs for privately insured patients at $35 a month. Competing drugmakers Novo Nordisk...